# Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin

> **NCT00487318** · PHASE2 · COMPLETED · sponsor: **Bader, Ted, M.D.** · enrollment: 40 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** standard of care
- **DRUG:** fluvastatin

## Key facts

- **NCT ID:** NCT00487318
- **Lead sponsor:** Bader, Ted, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487318, "Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00487318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*